CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 52 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-16 | Grissinger Michael Director | Grant or award | +3,135 | 6,024 | ||
| 2026-06-16 | Grissinger Michael Director | Grant or award · Stock Options (Right to Buy) | +12,555 | 12,555 | ||
| 2026-06-16 | Gruia Gabriela Director | Grant or award | +3,135 | 4,180 | ||
| 2026-06-16 | Gruia Gabriela Director | Grant or award · Stock Options (Right to Buy) | +12,555 | 12,555 | ||
| 2026-06-16 | Peters Richard Director | Grant or award | +3,135 | 6,254 | ||
| 2026-06-16 | Peters Richard Director | Grant or award · Stock Options (Right to Buy) | +12,555 | 12,555 | ||
| 2026-06-16 | HENNEMAN JOHN B III Director | Grant or award | +3,135 | 13,364 | ||
| 2026-06-16 | HENNEMAN JOHN B III Director | Grant or award · Stock Options (Right to Buy) | +12,555 | 12,555 | ||
| 2026-06-16 | BIZZARI JEAN-PIERRE Director | Grant or award | +3,135 | 4,180 | ||
| 2026-06-16 | BIZZARI JEAN-PIERRE Director | Grant or award · Stock Options (Right to Buy) | +12,555 | 12,555 | ||
| 2026-06-16 | Duey Marc Director | Grant or award | +3,135 | 259,290 | ||
| 2026-06-16 | Duey Marc Director | Grant or award · Stock Options (Right to Buy) | +12,555 | 12,555 | ||
| 2026-06-16 | Pamukcu Rifat Director | Grant or award | +3,135 | 8,581 | ||
| 2026-06-16 | Pamukcu Rifat Director | Grant or award · Stock Options (Right to Buy) | +12,555 | 12,555 | ||
| 2026-06-16 | Seizinger Bernd R. Director | Grant or award | +3,135 | 48,910 | ||
| 2026-06-16 | Seizinger Bernd R. Director | Grant or award · Stock Options (Right to Buy) | +12,555 | 12,555 | ||
| 2026-03-31 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase · Pre-Funded Warrant | +30,978 | $0.81 | $25K | 30,978 |
| 2026-03-31 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase · Common Warrant | +30,978 | 30,978 | ||
| 2026-03-31 | Peters Richard Director | Purchase · Pre-Funded Warrant | +123,915 | $0.81 | $100K | 123,915 |
| 2026-03-31 | Peters Richard Director | Purchase · Common Warrant | +123,915 | 123,915 |
Page 1 of 10 · 197 trades